Report Categories
View AllRecent Articles
View All
Global GBLI Stock Sell Signals Overhead Buying 20260415
Aeva AEVA Stock Market Sentiment Surges Ahead 20260418
Templeton TEI Stock Fill Price 060 20260418
Meta Workforce Reduction and AI Investment Strategy Analysis
Can LCI Industries LCII stock keep rising today LCI Industries notches 74 EPS beat in strong Q4
Robin Energy RBNE Stock Investment Opportunities 234 20260420
Market Wrap Tech leads sectors as consumer groups lag amid mild dip
BioCryst BCRX Slides 402 as Selling Pressure Mounts 20260515
LCI Industries LCII Delivers Q1 2026 Beat EPS 259 vs 224 Expected
Trumps Beijing Visit A Spectacle of Diplomacy DealMaking and Tech Ties
Medpace Holdings MEDP Q1 2026 Earnings Beat Revenue NA EPS 428
UK Growth Forecast Upgraded by IMF for 2025 But Risks Remain
Gartner IT Stock Analysis 123 Gain What to Watch 20260514
US Jobless Claims Drop to Lowest Level Since MidMay Signaling Resilient Labor Market
Geopolitical Tensions Rise Fresh US Strikes Complicate Iran Nuclear Deal Negotiations
Tyson Foods Appoints Director as New CEO in Leadership Transition
Indias Consumption Reset Shift Toward Experiences and Premium Goods Reshapes Market
Federal Reserve Dissenters Explain Opposition to Signal of Rate Cuts Kashkari Logan Hammack Cite Economic Uncertainty
Nvidias Market Cap Overtakes Germanys GDP Tech Giants Rival Top Economies
FRPH Q4 2024 Earnings Modest Earnings Amid Stock Decline
ICFI Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises on Positive Market Sentiment
CG Q1 2026 Earnings EPS Miss with 844 Surprise
Globant Q1 2026 Earnings EPS Slightly Below Estimates Stock Slips
UZD Q1 2026 Earnings Significant EPS Beat Driven by Strong Operational Performance
Tutor Perini Corporation TPC Q1 2026 Earnings Strong EPS Beat Amid Revenue Disappointment
Laureate Education LAUR Gains 127 Approaches Key Resistance Zone
First Mid Bancshares Edges Lower Testing Support at 4386
OFS Credit Company OCCI Slides 21 as Pressure Mounts on Key Support
Arm Holdings ARM Surges Over 10 as AI Momentum Continues
CanFite Biopharma CANF Slides 262 Toward 318 Support as Selling Pressure Persists